[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[3]
|
Sasako, M., Sakuramoto, S., Katai, H., et al. (2011) Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy with S-1 versus Surgery Alone in Stage II or III Gastric Cancer. Journal of Clinical Oncology, 29, 4387-4393. https://doi.org/10.1200/JCO.2011.36.5908
|
[4]
|
Cunningham, D., Allum, W.H., Stenning, S.P., et al. (2006) Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. The New England Journal of Medicine, 355, 11-20.
https://doi.org/10.1056/NEJMoa055531
|
[5]
|
Heinemann, V. and Moosmann, N. (2007) Neoadjuvant and Adjuvant Therapies for Solid Tumours. MMW Fortschritte der Medizin, 149, 27-30. https://doi.org/10.1007/BF03365172
|
[6]
|
张晓杰, 赵东兵. 局部进展期胃癌新辅助化疗疗效预测进展[J]. 癌症进展, 2021, 19(8): 761-764.
|
[7]
|
Tchernof, A. and Després, J.P. (2013) Pathophysiology of Human Visceral Obesity: An Update. Physiological Reviews, 93, 359-404. https://doi.org/10.1152/physrev.00033.2011
|
[8]
|
Silveira, E.A., Kliemann, N., Noll, M., et al. (2021) Visceral Obesity and Incident Cancer and Cardiovascular Disease: An Integrative Review of the Epidemiological Evidence. Obesity Reviews, 22, e13088.
https://doi.org/10.1111/obr.13088
|
[9]
|
Qi, J., Hu, H., Yaghjyan, L., et al. (2020) Association of Adipose Tissue Distribution with Type 2 Diabetes in Breast Cancer Patients. Breast Cancer: Basic and Clinical Research, 14. https://doi.org/10.1177/1178223420972369
|
[10]
|
Carr, J.S., Zafar, S.F., Saba, N., et al. (2013) Risk Factors for Rising Incidence of Esophageal and Gastric Cardia Adenocarcinoma. Journal of Gastrointestinal Cancer, 44, 143-151. https://doi.org/10.1007/s12029-013-9480-z
|
[11]
|
Miyazaki, R., Hoka, S. and Yamaura, K. (2019) Visceral Fat, But Not Subcutaneous Fat, Is Associated with Lower Core Temperature during Laparoscopic Surgery. PLoS ONE, 14, e0218281.
https://doi.org/10.1371/journal.pone.0218281
|
[12]
|
Feng, W., Huang, M., Zhao, X., et al. (2020) Severe Loss of Visceral Fat and Skeletal Muscle after Chemotherapy Predicts Poor Prognosis in Metastatic Gastric Cancer Patients without Gastrectomy. Journal of Cancer, 11, 3310-3317.
https://doi.org/10.7150/jca.37270
|
[13]
|
Fujiwara, N., Nakagawa, H., Kudo, Y., et al. (2015) Sarcopenia, Intramuscular Fat Deposition, and Visceral Adiposity Independently Predict the Outcomes of Hepatocellular Carcinoma. Journal of Hepatology, 63, 131-140.
https://doi.org/10.1016/j.jhep.2015.02.031
|
[14]
|
Park, H.S., Kim, H.S., Beom, S.H., et al. (2018) Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat after Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the Classic Trial. Annals of Surgical Oncology, 25, 3222-3230. https://doi.org/10.1245/s10434-018-6624-1
|
[15]
|
Miljkovic, I. and Zmuda, J.M. (2010) Epidemiology of Myosteatosis. Current Opinion in Clinical Nutrition and Metabolic Care, 13, 260-264. https://doi.org/10.1097/MCO.0b013e328337d826
|
[16]
|
黎介寿. 临床营养支持的发展趋势[J]. 肠外与肠内营养, 2010, 17(1): 1-4.
|
[17]
|
江志伟, 黎介寿, 李宁. 恶性肿瘤病人的肠内营养支持[J]. 肠外与肠内营养, 2004(2): 118-121.
|
[18]
|
Blauwhoff-Buskermolen, S., et al. (2016) Loss of Muscle Mass during Chemotherapy Is Predictive for Poor Survival of Patients with Metastatic Colorectal Cancer. Journal of Clinical Oncology, 34, 1339-1344.
https://doi.org/10.1200/JCO.2015.63.6043
|
[19]
|
Stene, G.B., et al. (2015) Changes in Skeletal Muscle Mass during Palliative Chemotherapy in Patients with Advanced Lung Cancer. Acta Oncologica, 54, 340-348. https://doi.org/10.3109/0284186X.2014.953259
|
[20]
|
Windsor, J.A. and Hill, G.L. (1988) Grip Strength: A Measure of the Proportion of Protein Loss in Surgical Patients. British Journal of Surgery, 75, 880-882. https://doi.org/10.1002/bjs.1800750917
|
[21]
|
Becker, K., Mueller, J.D., Schulmacher, C., et al. (2003) Histomorphology and Grading of Regression in Gastric Carcinoma Treated with Neoadjuvant Chemotherapy. Cancer, 98, 1521-1530. https://doi.org/10.1002/cncr.11660
|
[22]
|
Shen, W., Punyanitya, M., Wang, Z., et al. (2004) Total Body Skeletal Muscle and Adipose Tissue Volumes: Estimation from a Single Abdominal Cross-Sectional Image. Journal of Applied Physiology (1985), 97, 2333-2338.
https://doi.org/10.1152/japplphysiol.00744.2004
|
[23]
|
石志文, 李娟, 曾欣, 谢渭芬. L_3骨骼肌指数在疾病预后评估中的应用[J]. 第二军医大学学报, 2019, 40(4): 420-425.
|
[24]
|
Su, H., Ruan, J., Chen, T., et al. (2019) CT-Assessed Sarcopenia Is a Predictive Factor for Both Long-Term and Short-Term Outcomes in Gastrointestinal Oncology Patients: A Systematic Review and Meta-Analysis. Cancer Imaging, 19, 82. https://doi.org/10.1186/s40644-019-0270-0
|
[25]
|
Yang, M., Shen, Y., Tan, L., et al. (2019) Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-Analysis. Chest, 156, 101-111. https://doi.org/10.1016/j.chest.2019.04.115
|
[26]
|
Aleixo, G., Williams, G.R., Nyrop, K.A., et al. (2019) Muscle Composition and Outcomes in Patients with Breast Cancer: Meta-Analysis and Systematic Review. Breast Cancer Research and Treatment, 177, 569-579.
https://doi.org/10.1007/s10549-019-05352-3
|
[27]
|
Li, J., Deng, Y., Zhang, M., et al. (2019) Prognostic Value of Radiologically Determined Sarcopenia Prior to Treatment in Urologic Tumors: A Meta-Analysis. Medicine (Baltimore), 98, e17213.
https://doi.org/10.1097/MD.0000000000017213
|
[28]
|
季锐, 汤光宇, 诸静其. 消化系统恶性肿瘤相关肌少症的影像学研究进展[J]. 国际医学放射学杂志, 2020, 43(4): 457-462.
|